Europe — EMA
Nodoryl Dolo (Metamizole Sodium Monohydrate)
GNH USA supplies Nodoryl Dolo (Metamizole Sodium), a non‑opioid analgesic for mild to moderate pain and fever. Request a quote for global supply.
Request sourcing
What is Metamizole Sodium Monohydrate?
Metamizole sodium monohydrate, the active ingredient in Nodoryl Dolo, is a non‑opioid analgesic (pyrazolone derivative) presented as an oral dosage form for oral use. It is indicated for the relief of mild to moderate pain and for the reduction of fever in adult patients.
GNH USA supplies Nodoryl Dolo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution.
What is Metamizole Sodium Monohydrate used for?
Metamizole sodium is used as an analgesic and antipyretic, acting on pain and fever pathways.
Mild to moderate pain: provides effective analgesic relief in conditions such as musculoskeletal discomfort, postoperative pain, and dental pain. Fever: reduces elevated body temperature in acute febrile states. Visceral colic: alleviates spasm‑related discomfort such as biliary or renal colic.
What are the side effects of Metamizole Sodium Monohydrate?
Metamizole sodium may cause a range of adverse reactions, varying from mild to severe.
Common Side Effects: - Nausea or vomiting - Dizziness or headache - Mild hypotension - Skin rash or itching
Serious or Rare Side Effects: - Agranulocytosis or severe leukopenia - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Anaphylactic reactions - Hepatic or renal impairment
What precautions apply to Metamizole Sodium Monohydrate?
When prescribing Metamizole sodium, several safety considerations should be observed.
Renal impairment: use with caution and monitor renal function. Hepatic disease: avoid or reduce dose in patients with liver dysfunction. History of blood disorders: contraindicated in patients with agranulocytosis or severe leukopenia. Concomitant NSAIDs or anticoagulants: increased risk of gastrointestinal bleeding. Pregnancy and lactation: safety not established; avoid unless benefit outweighs risk. Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.
What does Metamizole Sodium Monohydrate interact with?
Metamizole sodium can interact with several medicines, requiring attention to avoid harmful effects.
Major Interactions (Avoid): - Cytotoxic agents (e.g., cyclophosphamide): risk of severe bone‑marrow suppression. - Anticoagulants (e.g., warfarin): increased bleeding tendency. - Other pyrazolones: additive toxicity.
Moderate Interactions (Monitor Closely): - ACE inhibitors: may enhance hypotensive effect. - Diuretics: may increase risk of renal impairment. - Lithium: may raise lithium plasma concentrations.



